June 2020
Volume 61, Issue 7
ARVO Annual Meeting Abstract  |   June 2020
Incidence of epiretinal membrane progression after cataract surgery
Author Affiliations & Notes
  • Cristy Ku
    Ophthalmology, Ross Eye Institute, University at Buffalo, Buffalo, New York, United States
  • Franklin Jeng
    Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States
  • Vineela Varikuti
    Ophthalmology, Ross Eye Institute, University at Buffalo, Buffalo, New York, United States
  • David Diloreto
    Ophthalmology, Flaum Eye Institute, University Rochester, Rochester, New York, United States
  • Gareth Lema
    New York Eye and Ear of Mount Sinai, New York, United States
  • Footnotes
    Commercial Relationships   Cristy Ku, None; Franklin Jeng, None; Vineela Varikuti, None; David Diloreto, None; Gareth Lema, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1078. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cristy Ku, Franklin Jeng, Vineela Varikuti, David Diloreto, Gareth Lema; Incidence of epiretinal membrane progression after cataract surgery. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1078.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Epiretinal membranes occur in 19% of the population, and are associated with age, diabetes, and history of cataract extraction (CE). We investigated the progression of ERM after CE to aid in peri-operative management.

Methods : Retrospective review of records from January 2015 to January 2019 was performed. Of those meeting these criteria, 39 patients with ERM and CE, and 42 controls with ERM without CE were compared, with an end-point of 15 months of ERM progression analysis.

Results : Following cataract surgery, ERMs remained stable in 36% of eyes and worsened in 64%. In contrast, ERMs were stable in 60% and worsened in 40% of eyes without CE (p < 0.025, Chi-square analysis). Worsening ERMs were defined as decreased VA greater than 3 lines, symptomatic metamorphopsia, worsening traction or increased retinal thickness on optical coherence tomography. Additionally, worsening of ERMs occurred within 1 to 2 months following CE in 84% of the patients with ERM progression. Both groups had similar incidences of co-existing conditions of peripheral retinal tears, dry AMD, posterior vitreous detachment, and high myopia. There were differences in the incidence of diabetes, and history of prostaglandin use, and these co-morbidities may be contributory to ERM progression.

Conclusions : ERM progression is higher following cataract surgery.

This is a 2020 ARVO Annual Meeting abstract.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.